Intramuscular immunization with a monogenic plasmid DNA tuberculosis vaccine: Enhanced immunogenicity by electroporation and co-expression of GM-CSF transgene

Vaccine

Volumn 25, Issue 7, 2007, Pages 1342-1352

  Zhang, Xizhong ^a   Divangahi, Maziar ^a   Ngai, Patricia ^a   Santosuosso, Michael ^a   Millar, James ^a   Zganiacz, Anna ^a   Wang, Jun ^a   Bramson, Jonathan ^a   Xing, Zhou ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

DNA vaccines; Electroporation; GM CSF; Tuberculosis

Indexed keywords

BCG VACCINE; DNA VACCINE; GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; BCG VACCINATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ELECTROPORATION; FEMALE; GENE EXPRESSION; GM CSF GENE; IMMUNOGENICITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSGENE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BCG VACCINE; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; COLONY COUNT, MICROBIAL; ELECTROPORATION; FEMALE; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; INJECTIONS, INTRAMUSCULAR; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; PLASMIDS; TRANSGENES; TUBERCULOSIS VACCINES; VACCINES, DNA;

EID: 33845888804     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.089     Document Type: Article

References (38)

1. WHO. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2006, 362 (2006), World Health Organization, Geneva
2. Corbett E.L., Watt C.J., Walker N., Maher D., Williams B.G., Raviglione M.C., et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163 (2003) 1009-1021
3. Espinal M.A., Laszlo A., Simonsen L., Boulahbal F., Kim S.J., Reniero A., et al. Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against tuberculosis and lung disease working group on an-tituberculosis drug resistance surveillance. N Engl J Med 344 (2001) 1294-1303
4. Orme I.M. Prospects for new vaccines against tuberculosis. Trends Microbiol 3 (1995) 401-404
5. Wang J., and Xing Z. Tuberculosis vaccines: the past, present and future. Expert Rev Vaccines 1 (2002) 341-354
6. Huygen K. On the use of DNA vaccines for the prophylaxis of mycobacterial diseases. Infect Immun 71 (2003) 1613-1621
7. Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., Deck R.R., et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine. Nat Med 2 (1996) 893-899
8. Wang J., Thorson L., Stokes R.W., Santosuosso M., Huygen K., Zganiaz A., et al. Single mucosal, but not parenteral, immunization with recombinant adnoviral-based vaccine provides potent protection from pulmonary tuberculosis. J Immunol 173 (2004) 6357-6365
9. Kamath A.T., Feng C.G., Macdonald M., Briscoe H., and Britton W.J. Differential protective efficacy of DNA vaccines expressing secreted proteins of mycobacterium tuberculosis. Infect Immun 67 (1999) 1702-1707
10. Tanghe A., Lefevre P., Denis O., D'Souza S., Braibang M., Lozes E., et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. J Immunol 162 (1999) 1113-1119
11. Coler R.N., Skeiky Y.A.W., Vedvick T., Bement T., Ovendale P., Campos-Neto A., et al. Molecular cloning and immunologic reactive of a novel low molecular mass antigen of mycobacterium tuberculosis. J Immunol 161 (1998) 2356-2364
12. Coler R.N., Campos-Neto A., Ovendale P., Day F.H., Fling S.T., Zhu L., et al. Vaccination with the T cell antigen M. tb 8.4 protects against challenge with mycobacterium tuberculosis. J Immunol 166 (2001) 6227-6235
13. Li Z.M., Howard A., Kelley C., Delogu G., Collins F., and Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun 67 (1999) 4780-4786
14. Morris S., Kelly C., Howard A., Li Z., and Collins F. The immunogenicity of single and combination DNA vaccines against tuberculosis. Vaccine 18 (2000) 2155-2163
15. Lowrie D.B., Silva C.L., Colston M.J., Ragno S., and Tascon R.E. Protection against tuberculosis by a plasmid DNA vaccine. Vaccine 15 (1997) 834-838
16. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9 (1991) 271-296
17. Wang J., Snider D.P., Hewlett B.R., et al. Transgenic expression of granulocyte-macrophage colony-stimulating factor induces the differentiation and activation of a novel dendritic cell population in the lung. Blood 95 (2000) 2337-2345
18. Xing Z., Gauldie J., Tremblay G.M., Hewlett B.R., and Addison C. Intradermal transgenic expression of granulocyte-macrophage colony-stimulating factor induces neutrophilia, epidermal hyperplasia, Langerhans' cell/macrophage accumulation, and dermal fibrosis. Lab Invest 77 (1997) 615-622
19. Fischer H.G., Frosch S., Reske K., and Reske-Kunz A.B. Granulocyte-macrophage colony-stimulating factor activates macrophages derived from bone marrow cultures to synthesis of MHC class II molecules and to augment antigen presentation function. J Immunol 141 (1988) 3882-3888
20. Chang C.H., Furue M., and Tamaki K. B7-1 expression of Langerhans cells is upregulated by proinflammatory cytokines, and is downregulated by interferon- or by interleukin-10. Eur J Immunol 25 (1995) 394-398
21. McCormick S., Santosuosso M., Zhang X., and Xing Z. Manipulation of dendritic cells for host defense against intracellular infections. Biochem Soc Transac 34 (2006) 283-286
22. Wang J., Zganiacz A., and Xing Z. Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation. Vaccine 20 (2002) 2887-2898
23. Kamath A.T., Hanke T., and Britton W.J. Co-immunization with DNA vaccines expressing granulocyte-macrophage colony-stimulating factor and mycobacterial secreted proteins enhances T-cell immunity, but not protective against Mycobacterium tuberculosis. Immunology 96 (1999) 511-516
24. Dou J., Chen J.S., Wang J., Chen G.B., Zhao F.S., Tang Q., et al. Novel constructs of tuberculosis gene vaccine and its immune effect on mice. Cell Mol Immunol 2 (2005) 57-62
25. Wolff J.A., Malone R.W., Williams P., Chong W., Acsadi G., Jani A., et al. Direct gene transfer into mouse muscle in vivo. Science 247 (1990) 1465-1468
26. Somiari S., Glasspool-Malone J., Drabick J.J., Gilbert R.A., Heller R., Jaroszeski M.J., et al. Theory and in vivo application of electroporative gene delivery. Mol Ther 2 (2000) 178-187
27. Tollefsen S., Vordermeier M., Olsen I., Storset A.K., Reitan L.J., Clifford D., et al. DNA injection in combination with electroporation: a novel method for vaccination of framed ruminants. Scand J Immunol 57 (2002) 229-238
28. Tollefsen S., Tjelle T.E., Schneider J., Harboe M., Wiker G.H., Hewinson G., et al. Improved cellular and humoral immune responses against mycobacterium tuberculosis antigens after intramuscular DNA immunization combined with muscle eclectroporation. Vaccine 20 (2002) 3370-3378
29. Li Z.M., Zhang H.Y., Fan X.Y., Zhang Y., Huang J.L., Liu Q.L., et al. DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine 24 (2006) 4565-4568
30. Miller M., Rekas G., Dayball K., Wan Y., and Bramson J.L. The efficacy of electroporated plasmid vaccines correlates with long-term antigen production in vivo. Vaccine 22 (2004) 2517-2523
31. Santosuosso M., Zhang X., McCormick S., Wang J., Hitt M., and Xing Z. Mechanisms of mucosal and parenteral tuberculosis vaccinations: adenoviral-based mucosal immunization preferentially elicits sustained accumulation of immune protective CD4 and CD8 T cells within the airway lumen. J Immunol 174 (2005) 7986-7994
32. Malowany J., Santosuosso M., Zhang X., Aoki N., Ngai P., McCormick S., et al. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide or protein-loaded counterparts. Mol Ther 13 (2006) 766-775
33. Ravn P., Boesen H., Pedersen B.K., and Andersen P. Human T cell responses induced by vaccination with Mycobacterium bovis bacillus Calmette-Guerin. J Immunol 158 (1997) 1949-1955
34. Budker V., Budker T., Zhang G., Subbotin V., Loomis A., and Wolff J.A. Hypothesis: naked plasmid DNA is taken by cells in vivo by a receptor-mediated process. J Gene Med 2 (2000) 76-88
35. Aihara H., and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat Biotech 16 (1998) 867-870
36. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 12 (1994) 991-1045
37. Santosuosso M., McCormick S., Zhang X., Zganiacz A., and Xing Z. Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral BCG immunization against pulmonary tuberculosis. Infect Immun 74 (2006) 4634-4643
38. Romano M., D'Souza S., Adnet P.Y., Laali R., Jurion F., Palfliet K., et al. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Vaccine 24 (2006) 3353-3364